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A B S T R A C T
Hantaviruses cause two important human illnesses, hemorrhagic fever with renal syndrome (HFRS) and hantavirus
pulmonary syndrome (HPS). Both syndromes are believed to be immune-mediated diseases. Monocytes/macrophages are
thought to be the main target cells for hantaviruses and important sources of and targets for cytokines/chemokines secre-
tion. THP-1 cells have been used extensively as models for primary monocytes in biocompatibility research. The aim of
our study was to determine if hantaviruses induce the same immunoreactions in THP-1 cells and primary monocytes/
macrophages and might therefore be suitable for immune studies of hantaviral infections. For that purpose we compared
various cytokines/chemokines and their receptors in THP-1 cell line and primary monocytes/macrophages. Infected pri-
mary monocytes/macrophages induced mostly -chemokines and their receptors. In contrast, THP-1 cells, expressed re-
ceptors for CXC chemokines. Surprisingly, infected macrophages underwent morphological changes toward dendritic-
like cells and increased expression of co-stimulatory molecules: CD40, CD80, CD83 and CD86. Our data indicate that
THP-1 cells are not ideal for in vitro research of the immunopathogenesis of hantaviruses in humans. Further, our stud-
ies revealed potential roles for cytokines/chemokines in HFRS/HPS immunopathogenesis and point to intriguing possi-
bilities for the possible differentiation of infected macrophages to dendritic-like cells.
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Introduction
Hantaviruses cause two important human illnesses,
hemorrhagic fever with renal syndrome (HFRS) and
hantavirus pulmonary syndrome (HPS)1. HFRS is mani-
fested mainly by fever, variable degrees of circulatory
failure, hemorrhage and renal failure. In HPS, capillary
leakage is localized exclusively in the lungs, the kidneys
are largely unaffected, and death occurs from shock and
cardiac complications1. Several studies support the view
that HFRS/HPS are immune-mediated diseases2–6.
The in vivo study of the pathogenesis of HFRS and
HPS is limited by the lack of a suitable animal model. An
exception is Andes virus, which has been found to cause
HPS in humans and an HPS-like disease in hamsters7.
Consequently, most information on the immunopatho-
genesis of HFRS/HPS has been derived from the analysis
of patient samples2,4–6,8. Although such data are extre-
mely valuable, the available samples do not always repre-
sent the optimal window for measuring organ-specific
immune responses characteristic of the disease9.
Hantaviruses replicate in vitro in the cytoplasm of a
variety of mammalian cell lines, and in primary endothe-
lial cells and monocytes/macrophages10. Monocytes/ma-
crophages are thought to play a part in hantaviral spread
from the primary site of infection3,11–12. Kanerva et al.
suggested that mature macrophages show increased sus-
ceptibility to Puumala virus (PUUV) and that after dif-
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ferentiation to tissue macrophages they might function
in the spread of the virus during the infection12. It is also
known that human alveolar macrophages are permissive
for infection with Sin Nombre virus (SNV) and react with
low production of tumor necrosis factor alpha (TNF-)13.
We theorized that monocytes/macrophages could be im-
portant sources of and targets for cytokines/chemokines
secretion14.
THP-1 cells15, which were derived from the peripheral
blood of a 1-year-old male with acute monocytic leukae-
mia, have been used in numerous studies to measure
immunoreactions of human macrophages during infec-
tions. THP-1 cells have Fc and C3b receptors and lack
surface and cytoplasmic immunoglobulins. These cells
also stain positive for alpha-naphthyl butyrate esterase,
produce lysozymes, and are phagocytic. THP-1 cells can
also restore the response of purified T lymphocytes to
Concanavalin A, show increased CO2 production on pha-
gocytosis, and can be differentiated into macrophage-like
cells15. Although for some microorganisms that THP-1
cells are suitable for such research, there is evidence that
particular microorganisms may induce different immu-
noreactions in THP-1 cells than they do in primary hu-
man monocytes/macrophages16–18.
The aim of our study was to find out if pathogenic
hantaviruses will induce the same immunoreactions in
THP-1 cells and primary monocytes/macrophages, thus
would be suitable surrogates for the primary cells. Here
we report a comparative evaluation of cytokines/chemo-
kines and their receptors elicited by pathogenic han-
taviruses in the two types of cells.
Material and Methods
THP-1 cells and isolation of primary monocytes
The monomyelocitic THP-1 cell line (ATCC TIB 202)
and primary monocytes/macrophages were maintained
in RPMI 1640 medium (Life Technologies, Grand Island
NY) supplemented with 10% heat-inactivated fetal bo-
vine serum, 0.2% fungizone, 1% penicillin -streptomycin
and 1% glutamine (Life Technologies). For primary mo-
nocytes isolation, leukocytes were obtained by cytophe-
resis, after informed consent, from normal donors at the
National Institutes of Health (NIH). These cells repre-
sent excess existing samples derived from human donors
through approved NIH protocols (89-100/A-C and 99-
CC-0168). Monocytes were isolated from the leukocytes
by countercurrent centrifugal elutriation as described19.
The purity (>90%) of the monocyte preparations was
confirmed on cytocentrifuge slide preparations by mor-
phology with Wright’s staining. Monocytes were cultured
for 2–3 days before infection. After that period of culture,
>95% of the cells were adherent.
Viruses and infection
Hantaan virus (HTNV), strain 7611820, Andes virus
(ANDV) strain Chile-971786921, and Sin Nombre virus
(SNV), strain CC10722 propagated in Vero E6 cells (Vero
C1008, ATCC CRL 1586), were used to infect cells. Cells
were infected at multiplicities of infection (MOI) of 10–1
pfu/cell (SNV), 100 pfu/cell (ANDV), or 101 pfu/cell (HTNV).
The different MOI were used due to our inability to
achieve equivalent MOI, because of low-titer seed stocks
of some hantaviruses, like SNV. As controls for the in-
fected cultures, uninfected cells were treated identically
to infected cultures; that is, control cells were incubated
in the same medium that we used for diluting the viruses
before adsorption. The cells were then washed and refed
and maintained with appropriate medium. The cells
were incubated for 7–12 days at 37 °C, 5% CO2 and me-
dium was not changed during the observation period. All
infected and uninfected cells were tested for Mycoplasma
contamination by ELISA-PCR (Roche Diagnostics Cor-
poration, Roche Molecular Biochemicals, Indianapolis,
IN, USA) and were found to be Mycoplasma free.
Plaque assay
To confirm cell infection with HFRS- and HPS-caus-
ing viruses, supernatants of infected and uninfected cells
were collected at various times and were stored at –70 °C
until assayed. Plaque assays were performed as previ-
ously described using Vero E6 cell monolayers7.
Direct immunofluorescence assay for detecting
hantaviruses in infected cells
Slides of infected or uninfected cells, were fixed in ac-
etone and stained as previously described using a pri-
mary specific monoclonal antibody to the G2 protein of
HTNV (8E10) or hyperimmune mouse ascites fluid (HMAF)
to the specified hantavirus23.
RNA extraction and ribonuclease protection
assay (RPA)
Total cellular RNA was extracted using Trizol reagent
(Life Technologies) followed by phase separation with
chloroform, then precipitation with isopropyl alcohol.
Measurements of cytokines, chemokines and their recep-
tors were determined using a RiboQuant MultiProbe
RNAse protection system (PharMingen, San Diego, CA,
USA) and different multi-probe template sets (hCK-2,
hCR-4, hCR-5, hCR-6) following instructions provided by
the manufacturer. Quantitative comparisons of mRNA
expression levels among samples were made using a
CYCLONETM storage phosphorimaging system (Packard
Instrument Company, Meriden, CT) with molecular ana-
lysis software (Optiquant, version 3.0). The values ob-
tained for each level of mRNA measured were normal-
ized against the combined levels of expression obtained
for mRNA from GAPDH (glyceraldehyde-3-phosphate
dehydrogenase) and L32 housekeeping genes loaded
within the same lane on the RPA gel.
Enzyme-linked immunosorbent assay (ELISA)
Cytokines measured were: interleukin (IL)-1, IL-6,
IL-10, IL-12p40, granulocyte-macrophage colony-stimu-
lating factor (GM-CSF), interferon gamma (IFN-) and
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TNF-. Chemokines measured were: IL-8/CXCL-8, regu-
lated upon activation, normal T-cell expressed, and se-
creted (RANTES/CCL5), monocyte chemo-attractant
protein (MCP-1/CCL2) macrophage inflammatory pro-
tein- MIP-1/CCL3 and MIP-1/CCL4) levels were deter-
mined in the supernatants of infected (HTNV, SNV, ANDV)
and uninfected cells by specific ELISA (Pharmingen or
R&D Systems, Inc., Minneapolis, MN, USA) according to
the instructions provided by the manufacturer. Samples
were collected at various time points and stored at –70 °C
until assayed.
Giemsa-Wright staining
Slides with infected or uninfected THP-1 cells were
washed in PBS, 11 days after infection, fixed in metha-
A. Markoti} et al.: Pathogenic Hantaviruses and Human Monocytes, Coll. Antropol. 31 (2007) 4: 1159–1167
1161
Fig. 1. Detection of cytokines and chemokines in the supernatants of primary human monocytes and THP-1 monomyelocytic cells by en-
zyme-linked immunosorbent assay (ELISA). Hantaan virus (HTNV) induced granulocyte-macrophage colony-stimulating factor (GM-
CSF) (a) and tumor necrosis factor alpha (TNF-) (b) in primary monocytes. All three hantaviruses, HTNV, Sin Nombre (SNV), and An-
des virus (ANDV) induced -chemokines: macrophage inflammatory protein-1 alpha (MIP-1/CCL3), (c), MIP-1/CCL4 (d) and regu-
lated upon activation, normal T-cell expressed, and secreted (RANTES/CCL5) (f). In THP-1 cells only HTNV induced appreciable levels
of MIP-1/CCL4 (e) and RANTES/CCL5 (g).
nol, air dried, stained with Wright Giemsa stain for 5
min, then washed in distilled water and examined under
a microscope. This stain, which contains polychrome
methylene blue and eosin Y, is traditionally used for
staining blood smears, parasites and viral inclusions. We
used it for our studies to provide better resolution of cel-
lular details.
Flow cytometry
Infection of THP-1 cells with hantaviruses produced
an apparent alteration in THP-1 cell type morphology.
Cells became adherent and appeared to develop dendritic
cell-like characteristics. To assess if infection of THP-1
cells altered the expression of cellular markers, infected
cells were stained for expression of various cluster of dif-
ferentiation (CD) markers and examined by flow cyto-
metry as previously described4. Briefly, THP-1 cells were
infected with hantaviruses or were untreated and were
cultured for 9 days. At days 3, 5, 6, 7, 8 and 9 postin-
fection, 1 x 106 cells were harvested and stained with
monoclonal antibodies for CD14, CD40, CD80, CD83 or
CD86 (Pharmingen), or double stained for CD14 and
CD40, CD80, CD83 or CD86. Monoclonal antibodies were
directly conjugated to fluorochromes (FITC and PE).
Control cells were prepared using appropriate labeled
isotype controls. In addition uninfected cells were also
processed in a similar manner and left unstained. The
same was repeated with primary human monocytes 12
days after infection with hantaviruses.
Direct immunofluorescence (IFA) assay
Infection of primary monocytes with hantaviruses re-
sulted in changing of the cells’ morphology toward den-
dritic cell-like characteristics. To assess if infection of
primary monocytes altered the expression of cellular
markers, the slides of infected or uninfected cells were
fixed in acetone and stained for expression of various CD
markers and examined by direct IFA. Briefly, primary
monocytes were infected with hantaviruses or were un-
treated and were cultured for 11 days. Cells (infected and
uninfected) were stained with monoclonal antibodies for
either CD14, CD40, CD80, CD83 or CD86 (Pharmingen),
or double stained for CD14 and CD80. Monoclonal anti-
bodies were directly conjugated to fluorochromes (FITC
and PE).
Results
Detection of THP-1 cells and primary
monocytes/macrophages infection with
hantaviruses
Several human cell lines are susceptible to infection
with hantaviruses10. In this study, we infected primary
human monocytes/macrophages and THP-1 cells with
hantaviruses and confirmed the infection by plaque as-
say of supernatants and/or immunofluorescence anti-
body assays. Low viral titers ranging from 9,5 x 104 pfu
for SNV to 1,2 x 104 pfu for HTNV were detected in the
supernatants of human monocytes by plaque assay (data
not shown).
Hantaviruses induce different cytokines, chemokines
and their receptors in primary human monocytes
than they do in THP-1 monomyelocytic cells
In primary monocytes, HTNV induced GM-CSF (Fig-
ure 1a) and TNF- (Figure 1b). ANDV also induced low
levels of TNF- (Figure 1b) and all three viruses induced
MIP-1/CCL3 (Figure 1c), MIP-1/CCL4 (Figure 1d) and
RANTES/CCL5 (Figure 1f). In contrast, in THP-1 cells,
only HTNV induced MIP-1/CCL3 (Figure 1e) and low
levels of RANTES/CCL5 (Figure 1g). When we measured
mRNA for cytokines and their receptors in the infected
THP-1 cells, we found that SNV suppressed gene expres-
sion of IL-1RA (Figure 2a) and slightly suppressed ex-
pression of TNF-, IL-6 and TGF receptors (Figure 2b).
Further we found that all three hantaviruses that we
tested increased gene expression for receptors of CC
chemokines in infected primary monocytes: including
the CCR1 receptor for MIP-1/CCL3, and RANTES/
CCL5 and CCR5 receptors for MIP-1/CCL3, MIP-1/
CCL4 and RANTES/CCL5 (Figure 3a). Only HTNV in-
duced higher CCR1 and CCR5 mRNA expression in com-
parison with control cells on day 2 after infection, while
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Fig. 2. Detection of cytokines mRNA expression in THP-1 cells
infected with hantaviruses from 20 h to 6 days postinfection.
Ribonuclease protection assays showed that Sin Nombre virus
(SNV) in comparison to Hantaan virus (HTNV) or uninfected
THP-1 cells, down-regulated mRNA for interleukine-1 receptor
antagonist (IL-1RA) (a) and also slightly down-regulated the
gene-expression for tumor necrosis factor alpha (TNF) and tu-
mor growth factor (TGF) receptors (b).
three viruses induced higher levels 12 days after the in-
fection (Figure 3 a,b). The expression of CCR5 was about
3–14 times higher in infected than in control cells and
CCR1 expression was about 2-5-fold higher than in con-
trol cells 12 days after infection (Figure 3b). Surprisingly,
in THP-1 cells, hantaviruses induced expression of CXC
chemokine receptors. Both, HTNV and SNV induced
CXCR2, which is the receptor for CXCL8, and HTNV in-
duced CXCR3, which is the receptor for IP-10 and other
chemokines (Figure 3c).
Hantaviruses induce morphological changes
of primary human monocytes and THP-1 cells
toward dendritic-like cells
Unexpectedly, during our experiments, we found that
monocytes infected with HFRS- and HPS-causing han-
taviruses underwent morphological changes toward den-
dritic-like cells. Although we found specific differences in
the profiles of cytokines, chemokines and their receptors
between primary monocytes and THP-1 cells infected
with hantaviruses, both types of cells underwent mor-
phological changes (Figure 4). The most prominent mor-
phological changes in primary monocytes were observed
10–12 days after infection (Figure 4a–d). In infected
THP-1 cells, morphological changes were observed 48–72
h after infection. The most prominent changes toward
dendritic-like cell shapes in THP-1 cells attached to the
plastic were observed 5 to 7 days after infection with
HTNV (Figure 4e), SNV or ANDV (data are not shown).
Eight to 10 days after infection, both infected and control
THP-1 cells began to die.
Hantaviruses induce expression of CD40, CD80,
CD83 and CD86 in infected primary human
monocytes
To evaluate if the morphological changes that we ob-
served in the primary monocytes infected with hanta-
viruses coincided with the induction of co-stimulatory
molecules (CD40, CD80, CD86) or markers for the matu-
ration of dendritic cells (CD83), we performed two-color
flow cytometry with HTNV-infected THP-1 cells (5 days
after infection) or primary monocytes (11 days after in-
fection) with monoclonal antibodies to CD14, CD40,
CD80, CD83 and CD86. We did not observe the increased
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Fig. 4. Morphological changes in primary human monocytes and
THP-1 cells infected with hantaviruses. In comparison to unin-
fected primary human monocytes (a), Hantaan virus (HTNV) (b),
Sin Nombre virus (SNV) (c), and Andes virus (ANDV) (d) in-
duced morphological differentiation to dendritic-like cells. In
THP-1 cells, HTNV (e) ANDV, and SNV (data not shown) also in-
duced morphological changes.
Fig. 3. Detection of chemokine receptor’s mRNA expression in
primary human monocytes and THP-1 cells infected with han-
taviruses. Ribonuclease protection assays performed at 2 or 12
days postinfection showed that Hantaan virus (HTNV), Sin
Nombre virus (SNV) and Andes virus (ANDV) increased expres-
sion of chemokine receptors: CCR1 and CCR5 in infected as com-
pared to uninfected primary human monocytes (a). The highest
expression was induced by HTNV, 12 days after infection (b). In
contrast, in THP-1 cells all three hantaviruses induced expres-
sion of CXCR2, while HTNV induced expression of CXCR3 (c).
expression of any of the tested molecules in infected com-
pared to uninfected cells. In only one experiment, with
THP-1 cells infected with HTNV, did we observe a slight-
ly higher signal for CD40 than was seen in control cells
(data not shown). Because we observed morphological
changes in a low percentage of infected monocytes, we
suspected that flow cytometry might not be sensitive
enough to detect the changes in a large pool of cells. Con-
sequently, we fixed primary monocytes infected with
HTNV, SNV or ANDV, and performed IFA with specific
antibodies. We found that all three of the hantaviruses
induced higher expression of CD40, CD80, CD83 and
CD86 molecules than were seen in uninfected control
cells (Figure 5). When we double-stained primary mono-
cytes infected with HTNV with anti-CD14 and anti-CD80
antibodies we found that uninfected cells expressed only
CD14, while monocytes infected with HTNV co-expres-
sed CD14 and CD80 or lost CD14 and expressed only
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Fig. 5. Expression of co-stimulatory molecules on primary hu-
man monocytes infected with hantaviruses. In comparison to un-
infected primary monocytes, monocytes infected with Hantaan
(HTNV), Sin Nombre (SNV) or Andes ANDV viruses increased
expression of CD40, CD80, CD83 and CD86 by direct immuno-
fluorescence (IFA). In double IFA staining with CD14 and CD80
antibodies, uninfected monocytes expressed only CD14, while
monocytes infected with HTNV co-expressed CD14 and CD80 or
lost CD14 and expressed only CD80. We also confirmed by IFA
that primary monocytes were infected with hantaviruses. Blue-
dapi (nuclear stain); green-FITC (CD14); red-PE (CD40, CD80,
CD83 or CD86).
CD80. It is possible that some of the infected cells, which
lost CD14 and had only CD80, had already acquired the
dendritic cell-like phenotype, whereas the cells that co-
expressed both CD14 and CD80 might have been in a
transient phase between macrophage and dendritic cell-
like morphologies.
Discussion
Hemorrhagic fever with renal syndrome and HPS are
both thought to be mediated by immunopathological
mechanisms1,3,6. The selective induction of cytokine and
chemokine synthesis has been implicated as a common
contributing factor in the pathology of many diseases, in-
cluding acute infectious diseases4–6. The myelomonocytic
THP-1 cell line has been used extensively as a model for
primary monocytes in biocompatibility research. The
lipopolysaccharide (LPS)-induced transcriptional res-
ponse in the THP-1 cell line is very similar to primary pe-
ripheral blood mononuclear cell (PBMC)-derived macro-
phages. Therefore, THP-1 cells represent a good model
system for studying the mechanisms of LPS and NF-kB-
dependent gene expression16. In contrast, there are some
reports that show differences in immunoreactions in-
duced by certain microorganisms in these two cell types.
For example, Mycoplasma fermentans-derived high-mo-
lecular-weight material-stimulated induction of cytokine
mRNA expression is accompanied by different proto-on-
cogene responses in primary monocytes/macrophages
and THP-1 cells, which may represent different regula-
tory pathways of the two cell systems17. Likewise, in a
study in which the responses of monocytes and THP-1
cells to some dental materials were compared by measur-
ing TNF-? secretion, it was found that the monocytes
were 5–10 times less sensitive than the THP-1 cells to
these materials18. To date, however, there has been no in-
formation reported with regard to the use of THP-1 cells
as models for primary monocytes in hantavirus research.
In this study we sought to measure differences in
cytokine/chemokine profiles elicited by HFRS or HPS-
causing hantaviruses in THP-1 cell line and primary
monocytes/macrophages. When we infected human mo-
nocytes with various hantaviruses, we did not find any
noticeable differences in the cytokine/chemokine pro-
duced. However, a striking finding was that all of the
hantaviruses showed similar profiles in primary mono-
cytes and also in THP-1 cells, but the profiles displayed
differed between the cell types. That is, in primary mono-
cytes, the hantaviruses elicited proinflammatory cytoki-
nes and -chemokines, but in infected monomyelocytic
THP-1 cells they produced only low amounts of -che-
mokines.
Interestingly, when we measured gene expression of
mRNA in the THP-1 cells, we found that cells infected
with SNV had decreased levels of mRNA expression of
IL-1Ra, which is reported to serve an important role in
regulation of the potentially injurious effects of IL-1. In
other studies, there are examples in which increases in
circulating IL-1Ra have been detected during viral or
bacterial infections27. For example, the rapid induction of
IL-1Ra by LPS, IL-1 or IL-6 suggests that IL-1Ra acts as
an acute phase protein27. In our studies, we did not de-
tect IL-1 or IL-6 or their mRNAs in infected THP-1
cells. However, in THP-1 cells infected with the HFRS-
causing virus, HTNV, the mRNA level of IL-1Ra was not
down-regulated as it was for the HPS-causing virus,
SNV. In a recent clinical study it was found that non-car-
riage of the IL-1Ra allele 2 and IL-1 allele 2 might con-
tribute to susceptibility to HFRS caused by PUUV28.
Whether or not the down-regulation of IL-1Ra in THP-1
cells induced by SNV is similarly related to an increased
susceptibility to infection with SNV has yet to be deter-
mined.
Another intriguing finding appeared when we mea-
sured chemokine receptors. We were not surprised to
find increased expression of CCR1 and CCR5 in infected
primary monocytes, as CCR1 and CCR5 are receptors for
-chemokines. We assumed that -chemokines produced
by primary monocytes infected with hantaviruses would
have autocrine as well as paracrine effects. Surprisingly,
however, we found that hantavirus-infected THP-1 cells
displayed receptors for CXC chemokines. Our results
showing differences in the biological responses of pri-
mary human monocytes and THP-1 cells to -chemo-
kines, suggest that there is a lack of subsequent re-
sponses in THP-1 cells, which indicates some missing
link in the downstream signaling transduction path-
ways29. Our data suggest that THP-1 cells are not ideal
for in vitro research of the immunopathogenesis of han-
taviruses in humans, at least for cytokine/chemokine re-
search. However, we believe that THP-1 cells may be use-
ful for studying more general immune mechanisms of
hantaviral infections. Further parallel analysis of down-
stream signaling pathways in primary monocytes and
THP-1 cells infected with hantaviruses may yield inter-
esting results.
Unexpectedly, in our study, we observed that mono-
cytes/macrophages infected with hantaviruses differenti-
ated toward dendritic-like cells. It is known that hanta-
viruses may infect dendritic cells30, but the differentia-
tion of monocytes/macrophages infected with hantaviru-
ses to dendritic-like cells was not previously described.
Although we found more striking differences in cytoki-
ne/chemokine production in primary human monocytes
than in THP-1 cells, both types of monocytes differenti-
ated upon infection with hantaviruses. To substantiate
our morphological observation of dendritic-like cells, we
looked for expression of co-stimulatory molecules indi-
cating dendritic cells by FACS analysis. Although such
molecules were not detected with this method, we were
able to detect their expression in infected primary hu-
man monocytes by IFA staining of fixed cells. Thus, we
suspect that there were too few cells undergoing morpho-
logical changes to be measured by FACS analysis of the
molecules.
Viruses alone are not known to induce monocyte dif-
ferentiation toward dendritic cells. Earlier studies dem-
onstrated that HTNV can infect and activate immature
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dendritic cells, resulting in up-regulation of major histo-
compatibility complex (MHC), co-stimulatory and adhe-
sion molecules30. Although we do not have definitive
proof, our results suggest that hantaviruses may induce
monocyte differentiation toward dendritic cell-like mor-
phology; however, the low number of dendritic-like cells
that we observed may indicate that only certain mono-
cyte subsets may acquire dendritic cell-like characteris-
tics after infection with hantaviruses. Further study is
needed to confirm this hypothesis.
Our results suggest many possible roles for cyto-
kines/chemokines in HFRS/HPS immunopathogenesis
and point to several intriguing possibilities for the inter-
action of hantaviruses and macrophages and their possi-
ble differentiation to dendritic cell-like cells. However,
the generation of immunological data in cell culture or
even animal models, might not be an accurate reflection
of immune responses that occur in a targeted organ of a
patient. Therefore, our in vitro studies will need to be
confirmed in future clinical studies as well as additional
in vitro studies.
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PATOGENI HANTAVIRUSI UZROKUJU RAZLI^ITE IMUNOREAKCIJE U THP-1 STANICAMA
I PRIMARNIM HUMANIM MONOCITIMA I INDUCIRAJU DIFERENCIJACIJU MONOCITA U
STANICE SLI^NE DENDRITI^KIM STANICAMA
S A @ E T A K
Hantavirusi uzrokuju dvije va`ne bolesti u ljudi, hemoragijsku vru}icu s bubre`nim sindromom (HVBS) i hantavi-
rusni plu}ni sindrom (HPS). Za oba sindroma se pretpostavlja da su imunolo{ki posredovani. Monociti/makrofagi su
vjerojatno izvor i ciljne stanice za citokine/kemokine. THP-1 stanice se ~esto koriste kao model za primarne monocite u
biokompatibilnim istra`ivanjima. Cilj na{e studije je istra`iti mogu li hantavirusi inducirati iste imunoreakcije u THP-1
stanicama i primarnim monocitima/makrofagima i mogu li se koristiti za istra`ivanje imunoreakcija na hantaviruse. U
tom cilju smo komparirali indukciju razli~itih citokina/kemokina i njihovih receptora u THP-1 stanicama i primarnim
monocitima/makrofagima. Inficirani primarni monociti/makrofagi induciraju ve}inom -kemokine i njihove receptore.
Naprotiv, u THP-1 stanicama nalazimo ekspresiju CXC kemokina. Iznena|uju}a je bila promjena u morfologiji inficira-
nih stanica koje su poprimile oblik stanica sli~nih dendriti~kim stanicama, te povisile ekspresiju kostimulatornih mo-
lekula: CD40, CD80, CD83 and CD86. Na{a istra`ivanja pokazuju da THP-1 stanice nisu idealne za in vitro itra`ivanja
imunopatogeneze hantavirusa u ljudi. Nadalje, na{e studije potvr|uju va`nu ulogu citokina i kemokina u imunopato-
geneze HVBS/HPS i upu}uju na intrigantnu mogu}nost diferencijacije inficiranih makrofaga prema stanicama sli~nim
dendriti~kim stanicama.
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